Suppr超能文献

墨西哥城不同类型新冠疫苗接种后住院患者的临床和病毒学特征

Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City.

作者信息

Hernández-Terán Alejandra, Garcíadiego-Fossas Pamela, Villanueva-Reza Marco, Boukadida Celia, Taboada Blanca, Porras Eduardo, Ahumada-Topete Victor, Tapia-Diaz Kathia Elizabeth, Matías-Florentino Margarita, Pérez-García Marissa, Ávila-Ríos Santiago, Mejía-Nepomuceno Fidencio, Serna-Muñoz Ricardo, Juárez-Hernández Fortunato, Jiménez-Corona María Eugenia, Becerril-Vargas Eduardo, Barreto Omar, Martínez-Orozco Jose Arturo, Pérez-Padilla Rogelio, Arias Carlos F, Vázquez-Pérez Joel Armando

机构信息

Departamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, INER, Mexico City 14080, Mexico.

Departamento de Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, INER, Mexico City 14080, Mexico.

出版信息

Vaccines (Basel). 2022 Jul 26;10(8):1181. doi: 10.3390/vaccines10081181.

Abstract

Coronavirus disease 2019 (COVID-19) vaccines effectively protect against severe disease and death. However, the impact of the vaccine used, viral variants, and host factors on disease severity remain poorly understood. This work aimed to compare COVID-19 clinical presentations and outcomes in vaccinated and unvaccinated patients in Mexico City. From March to September 2021, clinical, demographic characteristics, and viral variants were obtained from 1014 individuals with a documented SARS-CoV-2 infection. We compared unvaccinated, partially vaccinated, and fully vaccinated patients, stratifying by age groups. We also fitted multivariate statistical models to evaluate the impact of vaccination status, SARS-CoV-2 lineages, vaccine types, and clinical parameters. Most hospitalized patients were unvaccinated. In patients over 61 years old, mortality was significantly higher in unvaccinated compared to fully vaccinated individuals. In patients aged 31 to 60 years, vaccinated patients were more likely to be outpatients (46%) than unvaccinated individuals (6.1%). We found immune disease and age above 61 years old to be risk factors, while full vaccination was found to be the most protective factor against in-hospital death. This study suggests that vaccination is essential to reduce mortality in a comorbid population such as that of Mexico.

摘要

2019冠状病毒病(COVID-19)疫苗能有效预防重症和死亡。然而,所使用的疫苗、病毒变体和宿主因素对疾病严重程度的影响仍知之甚少。这项研究旨在比较墨西哥城接种疫苗和未接种疫苗的患者的COVID-19临床表现及转归。2021年3月至9月,从1014例有记录的感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的个体中获取临床、人口统计学特征及病毒变体信息。我们对未接种疫苗、部分接种疫苗和完全接种疫苗的患者进行比较,并按年龄组分层。我们还建立了多变量统计模型,以评估疫苗接种状态、SARS-CoV-2谱系、疫苗类型和临床参数的影响。大多数住院患者未接种疫苗。在61岁以上的患者中,未接种疫苗者的死亡率显著高于完全接种疫苗者。在31至60岁的患者中,接种疫苗的患者(46%)比未接种疫苗的患者(6.1%)更有可能为门诊患者。我们发现免疫疾病和61岁以上的年龄是危险因素,而完全接种疫苗是预防院内死亡的最具保护作用的因素。这项研究表明,接种疫苗对于降低像墨西哥这样患有合并症人群的死亡率至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9874/9330015/eb89e9ccb20c/vaccines-10-01181-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验